A Phase III Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome
NCT02503189 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2017-05-17
Summary
The purpose of this study is to investigate the superiority of KCT-0809 to placebo, and to evaluate safety in dry eye patients with Sjögren's syndrome
Conditions
- Dry Eye With Sjögren's Syndrome
Interventions
- DRUG
-
KCT-0809 ophthalmic solution
- DRUG
Sponsors & Collaborators
-
Kissei Pharmaceutical Co., Ltd.
lead INDUSTRY
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Primary Completion
- 2017-01-31
Countries
- Japan
More Related Trials
-
A Phase II Study of KCT-0809 in Patients With Dry Eye Syndrome
NCT01427816 ·Status: COMPLETED ·Phase: PHASE2
-
MSCohi-O Lenses for Ocular Involvement in Sjögren's Syndrome
NCT07185139 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Assessing Safety and Efficacy of DE-089 Ophthalmic Solution in Patients With Dry Eye Disease
NCT03216096 ·Status: COMPLETED ·Phase: PHASE1
-
Late Phase II Confirmatory Study of DE-089 Ophthalmic Solution in Patients With Dry Eye
NCT01189032 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of TOP1630 for Dry Eye Syndrome
NCT03088605 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of SHR8028 Eye Drops for the Treatment of Dry Eye Disease
NCT05841043 ·Status: COMPLETED ·Phase: PHASE3
-
A Safety and Efficacy Study of 552-02 in Subjects With Dry Mouth Associated With Sjogren's Syndrome
NCT00852839 ·Status: COMPLETED ·Phase: PHASE2
-
Study of DE-089 Ophthalmic Solution in Patients With Dry Eye
NCT01101984 ·Status: COMPLETED ·Phase: NA
-
Study of TOP1630 for Dry Eye Syndrome
NCT03833388 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Exploratory Study for Dry Mouth in Patients With Sjögren's Syndrome
NCT00233363 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of AG-80308 in Dry Eye Patients
NCT05372107 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy, Safety and Immunological Evaluation of Tofacitinib in the Treatment of Primary Sjogren's Syndrome
NCT05087589 ·Status: UNKNOWN ·Phase: PHASE2
-
Phase 2 Study of KLS-0611 in Patients With Dry Eye Syndromes
NCT00721656 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of 0.05% Cyclosporine A Eye Drops Combined With Absorbable Tear Duct Plugs in the Treatment of Dry Eye in Sjögren's Syndrom
NCT07171710 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye Disease
NCT04084483 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating a New Therapy for Dry Eye in Patients With Sjögren's Syndrome
NCT07277257 ·Status: RECRUITING ·Phase: PHASE4
-
Safety, PK and Efficacy Study of SJP-0132 in Subjects With Dry Eye Disease
NCT04139122 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of SY-201 Ophthalmic Solution in Subjects With Dry Eye Disease
NCT05370495 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Assess the Efficacy and Safety of Abatacept in Adults With Active Primary Sjögrens Syndrome
NCT02915159 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating the Efficacy and Safety of TJO-087 in Moderate to Severe Dry Eye Disease Patients
NCT05245604 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study Evaluating the Efficacy and Safety of RCI001 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye
NCT07068958 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study to Evaluate the Safety, Tolerability, and Efficacy of A197 in Subjects With Dry Eye Disease
NCT05238597 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study Evaluating the Safety and Efficacy of SI-614 Ophthalmic Solution in Patients With Dry Eye
NCT01558999 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of SJP-0132 Eye Drops in Chinese Patients With Dry Eye Disease
NCT06717152 ·Status: COMPLETED ·Phase: PHASE3
-
Exosomes in Patients With Ocular Involvement of Sjögren's Syndrome
NCT07192666 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1